Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |